FR2437831A1 - Agent de contraste pour l'examen radiologique du foie et procede pour sa preparation - Google Patents

Agent de contraste pour l'examen radiologique du foie et procede pour sa preparation

Info

Publication number
FR2437831A1
FR2437831A1 FR7924619A FR7924619A FR2437831A1 FR 2437831 A1 FR2437831 A1 FR 2437831A1 FR 7924619 A FR7924619 A FR 7924619A FR 7924619 A FR7924619 A FR 7924619A FR 2437831 A1 FR2437831 A1 FR 2437831A1
Authority
FR
France
Prior art keywords
liver
preparation
contrast agent
radiological examination
phospholipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7924619A
Other languages
English (en)
French (fr)
Other versions
FR2437831B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAENIKER FELIX
Original Assignee
DAENIKER FELIX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAENIKER FELIX filed Critical DAENIKER FELIX
Publication of FR2437831A1 publication Critical patent/FR2437831A1/fr
Application granted granted Critical
Publication of FR2437831B1 publication Critical patent/FR2437831B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR7924619A 1978-10-05 1979-10-03 Agent de contraste pour l'examen radiologique du foie et procede pour sa preparation Granted FR2437831A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1033378A CH641682A5 (en) 1978-10-05 1978-10-05 X-ray contrast medium

Publications (2)

Publication Number Publication Date
FR2437831A1 true FR2437831A1 (fr) 1980-04-30
FR2437831B1 FR2437831B1 (https=) 1983-03-25

Family

ID=4362083

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7924619A Granted FR2437831A1 (fr) 1978-10-05 1979-10-03 Agent de contraste pour l'examen radiologique du foie et procede pour sa preparation

Country Status (3)

Country Link
CH (1) CH641682A5 (https=)
DE (1) DE2935195A1 (https=)
FR (1) FR2437831A1 (https=)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515960A1 (fr) * 1981-11-06 1983-05-13 Alkhouri Fallouh Nazir Nanocapsules ou nanoparticules biodegradables contenant une substance biologiquement active, leur preparation et leur application
FR2574297A1 (fr) * 1984-12-12 1986-06-13 Ceskoslovenska Akademie Ved Particules d'hydrogel spheriques, a effet de contraste, a base de polymeres et de copolymeres d'acrylates et de methacrylates, et procede pour leur preparation
EP0194644A3 (en) * 1985-03-15 1987-09-30 William Elson Shell Biodegradable microspheres and method for their preparation
WO1988009165A1 (en) * 1987-05-22 1988-12-01 Bracco Industria Chimica S.P.A. Injectable opacifying liposome composition
WO1996003155A1 (de) * 1994-07-26 1996-02-08 Schering Aktiengesellschaft Kontrastmittel zur darstellung der leber
US5676928A (en) * 1994-03-28 1997-10-14 Nycomed Imaging As Liposomes
WO2001024834A1 (en) * 1997-09-12 2001-04-12 See Jackie R Methods of preparing micro encapsulated agents for use in detection of tumors by ct imaging

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3934656A1 (de) * 1989-10-13 1991-04-18 Schering Ag Verfahren zur herstellung von waessrigen dispersionen
SE9101709L (sv) * 1991-06-03 1992-12-04 Karlshamns Lipidteknik Ab Lipidderivat som diagnostikum eller kontrastmedel

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
FR2132810A1 (https=) * 1971-04-10 1972-11-24 Schering Ag

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
US3356575A (en) * 1965-04-13 1967-12-05 Leo Ab Autosterile injectable iodinated oil X-ray contrast medium
FR2132810A1 (https=) * 1971-04-10 1972-11-24 Schering Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1973 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515960A1 (fr) * 1981-11-06 1983-05-13 Alkhouri Fallouh Nazir Nanocapsules ou nanoparticules biodegradables contenant une substance biologiquement active, leur preparation et leur application
FR2574297A1 (fr) * 1984-12-12 1986-06-13 Ceskoslovenska Akademie Ved Particules d'hydrogel spheriques, a effet de contraste, a base de polymeres et de copolymeres d'acrylates et de methacrylates, et procede pour leur preparation
EP0194644A3 (en) * 1985-03-15 1987-09-30 William Elson Shell Biodegradable microspheres and method for their preparation
WO1988009165A1 (en) * 1987-05-22 1988-12-01 Bracco Industria Chimica S.P.A. Injectable opacifying liposome composition
CH672733A5 (https=) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US5312615A (en) * 1987-05-22 1994-05-17 Bracco - Industria Chimica S.P.A. Injectable opacifying composition containing liposomes of high encapsulation capacity for X-ray examinations
US5445810A (en) * 1987-05-22 1995-08-29 Bracco International B.V. Injectable opacifying composition containing liposomes of high encapsulating capacity for X-ray examinations
US5626832A (en) * 1987-05-22 1997-05-06 Bracco S.P.A. Injectable opacifying composition containing liposomes of high encapsulation capacity for X-ray examinations
US5676928A (en) * 1994-03-28 1997-10-14 Nycomed Imaging As Liposomes
WO1996003155A1 (de) * 1994-07-26 1996-02-08 Schering Aktiengesellschaft Kontrastmittel zur darstellung der leber
WO2001024834A1 (en) * 1997-09-12 2001-04-12 See Jackie R Methods of preparing micro encapsulated agents for use in detection of tumors by ct imaging

Also Published As

Publication number Publication date
CH641682A5 (en) 1984-03-15
DE2935195A1 (de) 1980-04-17
FR2437831B1 (https=) 1983-03-25

Similar Documents

Publication Publication Date Title
Dowdle et al. Active transport of Fe59 by everted segments of rat duodenum
FR2437831A1 (fr) Agent de contraste pour l'examen radiologique du foie et procede pour sa preparation
IL86409A0 (en) Injectable aqueous suspensions of encapsulated x-ray opacifying agents
IL125311A0 (en) Metal complexes that contain perfluoroalkyl a process for their production a pharmaceutical composition containing the same and use thereof
NO923739L (no) Kontrastmidler
FR2303375A1 (fr) Circuit de correction de l'astigmatisme dans un tube a rayons cathodique
FR2420151A1 (fr) Support pour une cassette pour film radiographique
DE3366838D1 (en) Pharmaceutical composition
ATE50583T1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
Marks et al. Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones
ATE107167T1 (de) Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten.
EP0153992A3 (en) Water soluble derivatives of 3,5-diaceto amido-2,4,6-triiodobenzoic acid and process for their preparation and use
FR2364019A1 (fr) Procede et appareil de formation d'images tomographiques
FR2455334A1 (fr) Procede de preparation d'une solution de gallium 68 sous forme ionique
DE3889863D1 (de) Neue substituierte Dicarbonsäure-bis(3,5-dicarbamoyl-2,4,6-triiodanilide), Verfahren zu deren Herstellung sowie diese enthaltende Röntgenkontrastmittel.
WO2023201377A3 (en) Scission-enhanced nuclear imaging and treatment
EP0129152A3 (en) Triazolyl alcohols, process for their preparation and their use as fungicides
FR2536061B1 (fr) Procede pour ameliorer l'efficacite de la decontamination en ruthenium dans le traitement de l'acide nitrique par evaporation
Dhopeshwarkar et al. Role of phospholipids in iodine binding
AU557798B2 (en) Radiographic imaging composition
JPS57193473A (en) Vitamin e linoleic acid ester
EP0019790A3 (en) Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation; acetanilides and acetanilidoiminodiacetates and their preparation
DE20080372U1 (de) Mittel zur Vorbeugung des Jodmangels
IE56116B1 (en) Radioaerosol delivery apparatus
CH438584A (de) Röntgenkontrastmittel

Legal Events

Date Code Title Description
ST Notification of lapse